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Abstract.  Cells closely resembling epithelia constitute 
the first specific cell type in a mammalian embryo. 
Many other cell types emerge via epithelial-mesen- 
chymal differentiation. The transcription factors and 
signal transduction pathways involved in this differenti- 
ation are being elucidated. I have previously reported 
(Frisch,  1991) that adenovirus Ela is a tumor suppres- 
sor gene in certain human cell lines. In the present re- 
port, I demonstrate that Ela expression caused diverse 
human tumor cells (rhabdomyosarcoma, fibrosarcoma, 
melanoma, osteosarcoma) and fibroblasts to assume at 
least two of the following epithelial characteristics: (a) 
epithelioid morphology; (b) epithelial-type intercellular 
adhesion proteins localized to newly formed junctional 
complexes; (c) keratin-containing intermediate fila- 
ments; and (d) down-regulation of non-epithelial 
genes. Ela thus appeared to partially convert diverse 
human tumor cells into an epithelial phenotype. This 
provides a new system for molecular analysis of 
epithelial-mesenchymal interconversions. This effect 
may also contribute to Ela's tumor suppression 
activity, possibly through sensitization to anoikis 
(Frisch, S. M., and H.  Francis,  1994.  J.  Cell Biol. 
124:619-626). 
T  H~ Ela gene of adenovirus has been extensively inves- 
tigated for diverse reasons. When introduced into vari- 
ous human tumor cell lines, it acts as a tumor suppres- 
sor gene, not by killing tumor cells, but by converting them 
into a nontransformed  phenotype (Frisch, 1991). It regulates 
the transcription of several cellular genes positively or nega- 
tively (Shenk and Flint,  1991; Flint and Shenk, 1990; Jones 
et al.,  1988; Braithwaite et al., 1991) and represses a large 
number of promoters in transient  transfection  assays (Ro- 
chette-Egly et al., 1990). It facilitates the transformation of 
primary rodent cells by oncogenes such as ras (Ruley, 1983). 
It blocks the differentiation in culture of pheochromocytoma 
cells into neurons (Maruyama et al., 1987) or myoblasts into 
myotubes (Webster et al., 1988). In addition, Ela complexes 
with proteins such as retinoblastoma protein, p107 and p130, 
thereby interfacing with the cell cycle machinery via cyclins 
and the transcription  factor E2F (reviewed in Moran, 1993; 
Dyson and Harlow, 1992). 
The epithelial cell is characterized by its morphology, ex- 
tensive intercellular interactions through cell adhesion mole- 
cules (Ekblom et al.,  1986; Grunwald,  1991; Schmidt et 
al.,  1993), cell polarity  (Rodriguez-Boulan  and  Nelson, 
1992),  keratin-containing  intermediate filaments  (Steinert 
and Roop, 1988), and synthesis of basement membrane pro- 
teins. The epithelial-specific intercellular adhesions consist 
of adherens  junctions, tight junctions, and desmosomes. The 
major proteins involved forming these structures are: cadhe- 
rins and catenins (adherens junctions; reviewed in Takeichi, 
1991; Geiger and Ayalon,  1992), ZO-1, cingulin,  and oc- 
cludin (tight junctions;  reviewed  in  Citi,  1993), desmo- 
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plakin,  desmoglein,  desmocollin,  and plakoglobin (desmo- 
somes; reviewed in Koch et al., 1991; Buxton et al., 1993). 
These adhesions are critical for forming selectively perme- 
able epithelial sheets, for establishing  cellular polarity and 
for regulating  pattern formation, in epithelial  tissues  (re- 
viewed in Schmidt et al., 1993; Birchmeier and Birchmeier, 
1993; Grunwald,  1991). 
The results reported here show that the expression of Ela 
in certain nonepithelial cells induced the expression of genes 
encoding various  epithelial  cell-specific  adhesion  proteins 
and the formation of the appropriate intercellular adhesions. 
Other  epithelial  features,  such  as  synthesis  of  keratin- 
containing intermediate filaments, were induced in some of 
the cell lines as well. As such, Ela appeared to be capable 
of reprogramming gene expression to produce a partial  or 
complete epithelial phenotype, depending upon the original 
cell type. 
Materials and Methods 
Cell Lines 
The tumor cell lines used in this study, A204 rhabdomyosarcoma, HT1080 
fibrosarcorna, A2058 melanoma, and Saos-2 osteosarcoma and RD rhab- 
domyosarcoma were obtained  from American Type Culture  Collection 
(Rockville, MD) and subcloned before use. MCF-7 cells were from Ameri- 
can Type Culture Collection and were used without subeloning. The Li- 
Fraumeni fibroblast cell line 172 (Bischoff et al., 1990) was obtained from 
Dr. Michael Tainsky  (M. D. Anderson Cancer Center, Houston, TX). It 
had been passaged until loss of the wild-type allele of p53 was achieved (M. 
Tainsky, personal communication). HaCat cells were from R. Fusenig (Ger- 
man Cancer Center, Heidelberg, Germany). Construction of  Ela derivatives 
of the H4 subclone of HT1080  (Frisch and Francis,  1994) and of A2058 
melanoma cells (Frisch, 1991) were described. The Ela derivatives of the 
other  cell  lines  were  constructed  using  methods  described previously 
(Frisch and Francis, 1994) with the rctrovirus that contained the 12 S form 
of adenovirus-5 Ela under control of the SV-40 early promoter. 
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Western blots were performed using Immobilon filters (MiUipore Corp., 
Bedford,  MA), horseradish peroxidase-conjugated secondary  antibodies 
(Boehringer Mannheim  Biochemicals,  Indianapolis,  IN) and ECL detection 
(Amersham Corp., Arlington Heights,  IL). Primary antibodies were from 
the following sources:  anti-Ela clone M73 (Oncogene  Science Inc., Man- 
hasset, NY), anti-desmoplakin pelyclonal antibody NW6 (Kathleen Green, 
Northwestern University,  Evanston, IL), or anti-desmoglein monoclonal 
antibody (Pamela Cowin,  New  York  University,  New  York),  anti-des- 
moglein  monoclonal antibody  clone  3.10  (BioDesign,  Kennebunlq0ort, 
Maine), anti-ZO-1  polyclonal  antibody no.  7445 (James  Anderson, Yale 
University, Now Haven, CT), anti-pan-cadherin  polyclonal antibody C3678 
(Sigma  Chemical  Co.,  St.  Louis,  MO),  anti-E-cadherin (DECMA-1; 
Sigma),  anti-desmin (Oncogene  Science;  clone DE-B1).  In all Western 
blots, equal protein loading of the SDS-PAGE gels was confirmed by Amido 
black staining of the blots after development with the ECL reagent. 
Northern Blotting 
Northern blotting was  performed using formaldehyde-agarose  gels  and 
nitrocellulose  (Schleicher & Schuell,  Keene, NH) filters on RNAs (12 #g) 
that were prepared by guanidine thiocyanate/cesium  chloride gradients. 
Equal RNA loading was verified by photographing the ethidium bromide- 
stained gels prior to transfer, cDNA probes were made random-primer la- 
belling (Strategene Corp., La Jolla, CA) of restriction fragments in low-melt 
agarose  gel  slices.  Probes  were  from  the  following  sources:  human 
desmoplakin  (pDPI/II;  K.  Green,  Northwestern  University,  1,800-bp 
HindIII fragment), human desmnglein-2 (W. Franke, German Cancer Re- 
search Institute,  Heidelberg; phDsg2.pc2a, 800-bp EcoRI fragment), hu- 
man plakoglobin (W. Franke, pHPGCa2.1,  1540 bp SacI fragment), E-cad- 
herin (pCO5.3;  David Rimm, Yale University), human keratin 18 (pK189; 
R. Oshima, La Jolla Cancer Research Foundation; EcoRI/BamHI 1,078-bp 
fragment), human keratin 8 (pKS12; R. Oshima; XhoI/ScaI 1,496-bp frag- 
ment), human fibronectin  (pBS70K; Alex Morla, La Jolla Cancer Research 
Foundation;  EcoRI/Xbal  592-bp  fragment),  glyceraldehyde-phosphate- 
dehydrogenase (pGAPDH; I ATCC, 800-bp Xbal/PstI fragment), tyrosinase 
(pKS-E1-3.4-HR2.1;  M.  Spritz,  Yale University; 2.1-kb  HindIII-EcoRI 
fragment). 
Immunofluorescence 
Cells were grown on 2 cm gelatin-coated coverslips.  Fixation was either 
with cold methanol (1 rain for desmoplakin or desmoglein, l0 m for kera- 
tins) or with 1% paraformaldehyde  for other proteins (10 m) followed by 
l0 rain permeabilization in 0.1% Triton X-100. Images were photographed 
on a Zeiss Axiophot microscope using the 63 ×  lens. Antibodies were as 
described  above;  anti-keratin  18  was  monoclonal  CK5  (R.  Oshima). 
Sodium-potassium ATPase was localized by staining with 5 #g/ml anthroyl- 
ouabain (Sigma Chemical Co.) in complete growth medium for 30 rain, fol- 
lowed by three washes in medium and fluorescent microscopy  using a UV 
filter (G. Fortes, University of California at San Diego, San Diego, CA, per- 
sonal communication). 
Other Microscopy 
Domes were documented on a Zeiss LSM410 laser scanning microscope 
with  confocal  fluorescence  of laser  scanning bright field  and  images 
recorded digitally on disk. Final magnification  shown in photographs was 
365× (1 cm = 63 m). For electron microscopy, cells were fixed in modified 
Karnovsky's fixative (2% paraformaidehyde;  1.5% glutaraldehyde  in 0.1 M 
cacodylate,  pH 7.4) for 1-2 h at 4°C, postfixed  in 1% OsO4 in the same 
buffer for 1 h at room temperature (RT); transferred to 1% tannic acid in 
0.02 M cacodylate buffer for 30 min at RT and stained enblock in 1% aque- 
ous uranyl acetate for 1 h at RT. Fixed cells were dehydrated in graded etha- 
noI and flat-emhedded in epoxy resin. Thin sections were cut parallel to the 
culture dish and stained with uranyl acetate and lead citrate and viewed with 
a Hitachi HUI2-A electron microscope. 
1. Abbreviations used in this paper: aa, amino acid; DSG2, desmoglein-2; 
FIB, 172 fibroblast;  FS, HTI080 fibrosarcoma;  OS, Saos-2 ostcosarcoma; 
pGAPDH,  glyceraldehyde-phosphate-dehydrogenous;  RM,  A204  rhab- 
domyosarcoma;  RM2, RD rhabdomyosarcoma;  RT, room temperature. 
Electrical Resistance 
Cells (2  ×  105) were plated onto Falcon filter inserts (25 nun) that had 
been precoated for 1 h with 100 #g/ml Matrigel (Collaborative Research, 
Lexington, MA). 2 d later, electrical resistance across the filters was mea- 
sured  using  an  epithelial  voltohmeter  (World  Precision  Instruments, 
Sarasota, FL). 
Results 
Ela Expression Causes Conversion to an 
Epithelioid Morphology 
A  retrovirus  that  transduces  the  12  S  (243-amino  acids 
[aa]) form of adenovirus-5  Ela (Frisch,  1994) was used to 
generate stable Ela-expressing  cell lines from the following 
parental cells: HTI080 fibrosarcoma (FS), A204 rhabdomyo- 
sarcoma  (RM),  RD  rhabdomyosarcoma  (RM2),  Saos-2 
osteosarcoma (OS), and fibroblasts spontaneously immor- 
talized by deletion of p53 (Li-Fraumeni fibroblasts; FB); Ela 
derivatives  of A2058 constructed  by transfection  were de- 
scribed (Frisch,  1991).  Expression of Ela protein in G418- 
selected clones was verified by Western blotting (Fig.  1 a). 
All of the Ela-expressing  cell lines adopted an epithelioid 
morphology (Fig. 1 b). Because of the large variation in Ela 
expression levels amongst different G418-resistant  clones~ 
individual clones were analyzed instead of pooling together 
large numbers of clones, which could have introduced the 
risk of unpredictable  selection for a particular Ela expres- 
sion level. 
Expression of  Epithelial-type Cell Adhesions of 
Ela-expressing Cell Lines 
The morphologic properties of the Ela-expressing cell lines 
suggested that they had assembled epithelial-type junctional 
complexes.  This was investigated by electron microscopy, 
immunofluorescence, Western blotting, and Northern blot- 
ting. 
Desmosome formation requires the expression and assem- 
bly of demosplakin,  desmoglein, desmocollin, plakoglobin 
and other proteins (Koch et al.,  1991; Buxton et al.,  1993). 
Ela-expressing cell lines were subjected to immunofluo- 
rescence using anti-desmoplakin and desmoglein antibodies. 
Punctate pericytoplasmic structures closely resembling nor- 
mal desmosomes were detected with desmoplakin antibody 
in  Ela-expressing  fibrosarcoma  and  rhabdomyosarcoma 
(Fig. 2) but neither in parental nor in Ela-expressing deriva- 
tives of other parental cell lines.  In the fibrosarcoma cells, 
some perinuclear  staining  was also observed, which night 
reflect the binding of desmoplakin to intermediate filaments 
(Green and Jones, 1990). Although the desmosome density 
was lower in the  Ela/FS  than  in the  Ela/RM  cells,  well- 
formed  desmosomes  of double-leaflet  structure  (such  as 
those arrowed) were readily detectable. 
To determine whether Ela induced the expression of genes 
encoding  desmosomal proteins,  Northern  blots were per- 
formed. The desmoplakin gene was induced by Ela to vari- 
ous extents in all of the tumor cell lines examined (although 
very weakly in the osteosarcoma cells) as well as in fibro- 
blasts (Fig. 3). Expression of desmoglein-2 (DSG2), which 
is the form ubiquitously expressed in desmosome-bearing 
cells (Koch et al.,  1991; Buxton et al.,  1993), was induced 
by Ela in both of the rhabdomyosarcoma,  melanoma,  and 
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Expression of Ela protein in human tumor cells and fibroblasts in- 
fected with Ela retrovirus. Tumor cells were infected with the Ela- 
containing retrovirus, 4LNSX/8 (described in Frisch and Francis, 
1994) or by transfection in the case of the ML cells (Frisch, 1991). 
After selection of G418-resistant clones, Ela expression was tested 
by Western blotting using anti-Ela antibody M73. Cell lines are ab- 
breviated throughout as follows: fibroblasts (FB),  osteosarcoma 
(OS), rhabdomyosarcoma  (RM or RM2), melanoma  (ML), or fibro- 
sarcoma (FS). (b) Morphologies of representative Ela-expressing 
clones and "empty vector-infected" (control) cell lines were docu- 
mented by phase-contrast microscopy. 
fibroblast cell lines (Fig.  3 a).  (Western blotting revealed 
low-level DSG2 protein expression in the fibrosarcoma cells 
in  the  presence  or  absence  of  Ela;  data  not  shown.) 
Confirmation that desmoplakin and desmoglein proteins of 
correct molecular weight were induced by Ela was obtained 
by Western blotting lysates of  the most highly induced clone, 
Ela/RM No. 4.2 (Fig. 3 b).  Another desmosomal protein 
gene, desmocollin 3, was also induced by Ela in the RM and 
FS cells. 
The plakoglobin gene, whose protein is found both in des- 
mosomes and adherens junctions (where it is associated with 
cadherins) was induced by Ela in all of the cell lines exam- 
ined (Fig. 3) (except in RM2, where it was constitutively ex- 
pressed; data not shown). Overall, the fibrosarcoma and RM 
cells had the highest desmosomal protein expression levels 
and the detection of desmosomes by immunofluorescence 
was optimal in these cell lines. 
Electron microscopic analysis of the Ela-expressing RM 
cells revealed junctional structures, some of which resem- 
bled desmosomes (Fig. 4). These occurred in virtually every 
field; they could not be detected in the cells infected with 
control retrovirus. Although the electron microscopy alone 
was  not of sufficient resolution to unequivocally identify 
these cell structures as desmosomes, this interpretation was 
consistent with the immunofluorescence data. 
Electron microscopy (Fig. 4) also revealed the presence 
of extended electron-dense membranous junctions  in  the 
Ela/FS cells, as well as occasional desmosome-like struc- 
tures. The resolution of the electron microscopy did not per- 
mit a distinction between zonulae adherens versus tight  junc- 
tions (Stevenson et al., 1988).  However, they were detected 
only in the Ela-expressing derivative cell lines, and could not 
be detected in the cells infected with control retrovirus. 
Further  evidence  for  tight junctions  was  provided  by 
immunofluorescent and Western blot analysis of the tight 
junction protein  ZO-1  (Stevenson et  al.,  1986).  This  re- 
vealed weak, diffuse fluorescence in rhabdomyosarcoma cells, 
which was induced by Ela to a  level  and staining pattern 
similar to that found in epithelial cells (Fig. 5; Stevenson et 
al.,  1986, 1988),  indicating the presence of tight junctions. 
Pericytoplasmic ZO-1  staining was  found in the parental 
fibrosarcoma cells in a punctate pattern, consistent with the 
published observation that ZO-1 is expressed in some non- 
epithelial cell lines (Howarth et al.,  1992).  Ela caused the 
ZO-1  pattern staining to become more continuous in the 
fibrosarcoma cells, correlating with the incidence of  putative 
tight junctions observed by electron microscopy. 
Certain epithelial cells with well-formed tight junctions 
are reportedly capable of forming "domes: These structures 
result from the basolaterai localization of sodium-potassium 
ATPase, resulting in uptake of water beneath the cell layer 
to equilibrate the osmotic pressure.  Confluent cultures of 
Ela-expressing rhabdomyosarcoma cells were examined for 
dome formation by phase-contrast and confocal microscopy 
(Fig.  6).  Dome formation was observed at a  frequency of 
about 200  domes in 5  x  106  ceils.  No  domes were ob- 
served in the empty vector-infected parental  ceils.  Thus, 
Ela-expressing  cells  were  apparently  capable  of forming 
tight  junctions and polarizing to an extent that allowed dome 
formation. 
Direct  evidence  for  the  basolateral  localization of the 
sodium-potassium ATPase was obtained by staining con- 
Frisch et al. Ela/Epithelial Gene Expression Program  1087 Figure 2. Assembly of desmosomes in Ela-expressing RM and FS cell lines, (EIa/RM  or Ela/FS), or control cell lines (vec/RM, vec/FS). 
These were detected by immunofluorescence using anti-desmoplakin (ot-DP) or anti-desmoglein (ot-DG) antibodies, as described in 
Materials and Methods.  Particularly well-formed desmosomes in the Ela/FS cells are arrowed. 
The Journal of Cell Biology, Volume 127, 1994  1088 Figure 3. Expression of desmosomal  proteins in Ela-expressing  cell lines. RNAs from vector-infected  (E/a-) or Ela retrovirus-infected 
(E/a+) cell lines were probed on Northern blots (a) for desmoplakin (DP), desmoglein-2 (DSG2), plakoglobin (PG) or desmocollin-3 
(DSC3) expression.  To confirm expression of the corresponding protein of the correct molecular weight, Western blots (b) of indicated 
protein lysates were probed with DP or DSG2 antibodies, as described in Materials and Methods. Molecular weights were calculated rela- 
tive to rainbow markers (Amersham Corp.). Protein from a human keratinocyte  line HaCat was also run as a control. 
Figure 4.  Electron microscopic  analysis of cell-cell adhesions  in parental tumor cells  (vec/FS, vec/RM)  and Ela-expressing  (E/a/FS, 
Ela/RM) derivative ceils.  Electron microscopy  was carded out as described in Materials and Methods.  The positions of electron-dense 
putative adhesional  structures  are arrowed.  Bars,  1 #m. 
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pression and localization of the 
tight  junction  protein  ZO-1. 
(Left) Expression of ZO-1 pro- 
tein in rhabdomyosarcoma cells 
and Ela derivatives: analysis by 
Western blotting.  (Right) Im- 
munofluorescent localization of 
the tight junction protein ZO-1 
in control (vec/FS, ve/RM) and 
Ela-expressing  (Ela/FS, Ela/ 
RM) ceils. 
fluent monolayers of RM cells with anthroyl-ouabain (Fig. 
6). While the parental cells showed diffuse cytoplasmic dis- 
tribution, the Ela/RM cells showed the lateral staining pat- 
tern that is characteristic of epithelial cells. 
Functionality of the  tight junctions  was  also  tested  by 
measuring the electrical resistance across confluent sheets of 
Ela-expressing cells, which were grown on matrigel-coated 
filter inserts. The empty vector-infected  rhabdomyosarcoma 
cells had  no measurable  electrical resistance above filter 
background.  Ela/rhabdomyosarcoma  clone  No.  1  and 
MDCK (control) epithelial cells had resistances of 2501-1/ 
cm  2 and Ela/rhabdomyosarcoma clone No. 4.2 had a resis- 
tance  of 204  fl/cm  2.  Ela  induced  the  formation of tight 
junctions that could block ionic flow as efficiently as those 
in authentic epithelial cells. 
Homotypic interactions between cadherins on adjacent ep- 
ithelial cells can initiate junctional complex formation (e.g., 
Gurnbiner et al.,  1988; G-eiger and Ayalon, 1992). Because 
of  the large number of  cadherin family members (Geiger and 
Ayalon, 1992) protein lysates of  the Ela-expressing cell lines 
were initially probed with an antibody that recognizes all 
cadherins through a 21  aa conserved cytoplasmic epitope. 
Ela induction of a cadherin band was observed only in the 
RM cells (Fig. 7). This band was identified as E-cadherin by 
reaction with an E-cadherin-specific antibody (Fig.  7).  A 
Northern blot probed with an E-cadherin probe confirmed 
The Journal of Cell Biology,  Volume 127, 1994  1090 Figure 6.  Dome formation and polarized distribution of Na-K ATPase in Ela-expressing  RM cells.  (a) Domes were identified  by phase 
contrast microscopy as depicted in C and D; these represent  different  focal planes  where cells  around the top rim of the dome (C) or 
at the bottom surface (D) were in focus. A and B show confocal microscopy of a fluorescently  labeled  dome, viewing the xy plane (B) 
or along the xz plane (A). (b) The distribution of sodium-potassium ATPase in confluent cultures  of RM or Ela/RM cells was visualized 
by staining  with anthroyl-ouabain,  followed by fluorescence microscopy, as described in Materials  and Methods. 
that E-cadherin mRNA was induced by Ela in the RM (Fig. 
7) but not in the FS or RM2 cell lines  (data not shown). 
Induction of Other Epithelial Markers and Effects on 
Non-epithelial Markers 
Because  simple  epithelial  cells  contain  intermediate  ilia- 
ments composed of keratins  type 8  and  18 (Oshima et al., 
1983), Northern blots were probed to determine whether Ela 
induced these genes.  Ela induced keratin  18 expression in 
RM and melanoma cells and induced keratin 8 expression in 
the  RM  cells  (Fig.  8  a).  Based  on these  results,  keratin- 
containing intermediate filaments were expected to be found 
Figure 7. Expression of cadherins in Ela-expressing  cell lines.  (Top) A Western blot containing protein lysates from parental (-) or Ela- 
expressing  (+) cell lines was probed with pan-cadherin antibody or E-cadherin-specific antibody, as described in Materials  and Methods; 
lysates from mammary carcinoma cell line mcf-7 and from the keratinocyte cell line HaCat were used as positive  controls.  (Bottom) The 
Northern blot, containing RNAs from parental (-) or Ela-expressing  (+) RM cells was probed with an E-cadherin-cDNA probe. 
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expressing cell lines. (Left) The North- 
em blot, containing RNAs from paren- 
tal  (-) or Ela-expressing  (+)  RM  or 
ML cells was probed with human kera- 
tin 18 (K/8) or human keratin 8 (g8) 
probes, the expression levels were simi- 
lar to those  seen in HeLa cell control 
(data  not  shown).  (Middle)  Ela/RM 
clone 4.2, vec/RM (negative control) or 
mammary carcinoma mcf-7 cells were 
stained with anti-Kl8 antibody CK5 and 
photographed  on a fluorescence micro- 
scope. in the Ela-expressing rhabdomyosarcoma cells. Immunoflu- 
orescent antibody staining confirmed the presence of these 
intermediate filaments (Fig.  8 b). 
Ela did not induce gene expression globally. The gene for 
the glycolytic enzyme GAPDH was unaffected by Ela ex- 
pression (Fig. 9), except in the osteosarcoma cells, where it 
was slightly induced. 
To determine whether Ela repressed the expression of cer- 
tain nonepithelial genes, RM2 cells were probed for desmin 
protein, cardiac ot-actin mRNA and myoD mRNA (Fig. 9). 
The expression of these muscle-specific gene products was 
repressed by Ela. The melanocyte-specific tyrosinase gene 
was down-regulated in the melanoma cells as well. Ela also 
down-regulated the fibronectin gene, which is usually ex- 
pressed at higher levels in mesenchymal than in epithelial 
cells. 
Discussion 
Programmed interconversions between epithelial cells and 
mesenchymal cells occur during development (Hay,  1992). 
An important goal is to identify the regulatory molecul6s 
and mechanisms involved in these  interconversions.  This 
may also contribute to an understanding of  how the epithelial 
phenotype is  compromised by  oncogenic transformation. 
Because Ela is a viral gene, it is not normally involved in 
these interconversions. However,  analysis of them may be 
facilitated by the use of Ela, as demonstrated by the results 
presented herein. 
The adenovirus Ela gene was previously shown to be a tu- 
mor suppressor gene in various human cell lines (Frisch, 
1991).  Intuitively, a  tumor suppressor  gene might be ex- 
pected to revert tumor cells to their pre-transformed pheno- 
type. However, as reported herein, cell lines expressing Ela 
did not resemble their corresponding parental phenotypes; 
for example,  melanoma cells that expressed  Ela (Frisch, 
1991) did not morphologically resemble melanocytes. In- 
stead,  the morphologies of Ela-expressing cell lines con- 
strutted in this laboratory, as well as those depicted pho- 
tographicaUy  in  the  literature  (Maruyama  et  al.,  1987; 
Taylor et al., 1993) resembled that of  epithelial cells, regard- 
less of the parental cell type. The morphologic effects were 
clearly due to Ela expression rather than selection of sponta- 
neously occuring variants for the following reasons: (a) all 
of the parental cell lines were subcloned prior to introduc- 
tion of Ela; (b) after infection with the empty retrovirus vec- 
tor and G418  selection, no epithelioid colonies were ob- 
served; (c) every clone that expressed Ela had an epithelioid 
morphology; (d)  colonies of epitheloid morphology were 
observed within 3-5 d after infection, rendering the hypo- 
thetical requirement for secondary stochastic changes un- 
likely; and (e)  microinjection of Ela expression plasmids 
into HT1080 induced desmosomes which were detectable by 
immunofluorescence  two  days  after  injection  (data  not 
shown). 
The combined data in this report suggest that Ela is ca- 
pable  of programming  several  aspects  of  the  epithelial 
phenotype.  The effects  of Ela appeared to reflect an epi- 
thelial-specific programming event rather than generalized 
activation of transcription. The 243-aa Ela protein used in 
this study is not a general activator of transcription (Shenk 
and Flint, 1991; Berk, 1986; Braithwaite et al., 1991). It did 
not affect the expression of a housekeeping gene (GAPDH), 
and it repressed the expression of non-epithelial genes, indi- 
cating the specificity of Ela's effects. 
Certain genes have been shown previously to cause the 
loss of epithelial characteristics.  Oncogenes such as c-fos 
(Reichmann et al.,  1992)  and v-src (Warren and Nelson, 
Figure 9. Expression of housekeeping (GAPDH) or non-epithelial-specific genes (tyrosinase,  desmin, cardiac tx-actin,  fibronectin [FN], 
myoD) in Ela-expressing cell lines. Western blots (desmin) or Northern blots (other panels) were reacted with the anti-desmin antibodies 
or the appropriate eDNA probes as described in Materials and Methods. 
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ter factor (Schmidt et al.,  1993; Behrens et al.,  1991) can 
each cause epithelial cells to lose their intercellular  adhe- 
sions  and  polarity.  This  activity  of scatter  factor,  acting 
through the c-met receptor, may play an important role in the 
normal epithelial-mesenchymal  interactions.  Disruption of 
E-cadherin interactions,  either indirectly through c-met, or 
directly (by the use of anti-E-cadherin antibodies) causes the 
transient breakdown of most junctional complexes and loss 
of epithelial morphology. 
Ectopic  expression  of E-cadherin  in  fibroblasts  causes 
cell-cell  aggregation,  formation  of epithelial-type  cellular 
sheets  and  polarized  distribution  of certain  cell  surface 
markers  (Nagafuchi  et  al.,  1987;  Edelman  et  al.,  1987; 
NcNeill et al.,  1990).  The de novo induction of epithelial 
gene expression by E-cadherin has not been reported. How- 
ever, it is interesting that the RM cell line-the only cell line 
in which E-cadherin expression had been induced by Ela- 
showed the most comprehensive induction of other epithelial 
genes. Conceivably, the presence of E-cadherin could pro- 
mote epithelial gene induction by Ela in this cell line. It will 
be of interest to perform the appropriate transfection experi- 
ments to address this possibility. 
Developmentally, mesenchymal-epithelial transitions oc- 
cur during nephrogenesis, in which the product of the WT-1 
tumor suppressor/transcription  factor gene has been impli- 
cated, although the transfection of this gene has failed to ini- 
tiate the process in cultured cells (Rauscher, 1993). The 12 S 
form of Ela used in this study did not induce expression of 
WT-1  (data not shown). 
Epithelialization directed by two genes has very recently 
been reported. The extracellular signaling molecule encoded 
by Wnt-1 causes PC12 pheochromocytoma (neural  tumor) 
cells to adopt an epithelial morphology and elevated expres- 
sion of plakoglobin and E-cadherin  (Bradley et al.,  1993). 
Interestingly,  the  retinoic  acid-induced  neuronal  differen- 
tiation of P19 embryonal carcinoma cells involves an epithe- 
lioid intermediate  (Schmidt et al.,  1992). 
Epithelialization  of fibroblasts has been demonstrated in 
one rather complex system (Tsarfaty et al., 1994). When 3T3 
cells are cotransfected with the genes encoding scatter factor 
and the scatter factor receptor, c-met, and then injected into 
mice, tubular structures form whose cells express epithelial 
cell adhesion molecules. This epithelialization may involve 
a  complex  interplay  of matrix,  growth  factor,  and  cell- 
associated signals provided by the injected mouse. 
Ela thus appears to be the first protein capable of con- 
ferring  an  extensive  epithelial  commitment  upon  mesen- 
chymal cells in culture,  especially the rhabdomyosarcoma 
cells. Genes encoding epithelial cell adhesion molecules re- 
sponded to Ela to varying degrees in the various cell lines; 
however, cell type-specific responses of a given gene to a 
transcription  factor have been widely reported in the liter- 
ature. 
By what mechanism could Ela induce an epithelial pheno- 
type? Myogenic conversion by the muscle-specific transcrip- 
tion factor myoD involves the direct activation of muscle- 
specific  promoters.  However,  Ela  is  not  a  DNA-binding 
protein. In addition, because no epithelial-specific transcrip- 
tion factor has been indentified to date, a different paradigm 
should probably be invoked for epithelial conversion by Ela. 
The  "proto-epithelial"  cell  (Fleming  and  Johnson,  1988) 
emerges at around the time of compaction of the mamma- 
lian eight-cell embryo, being the earliest identifiable embry- 
onic cell type. It possesses intercellular adhesions involving 
E-cadherin,  tight junctions,  and cytokeratin filaments.  All 
primary  mesenchymal  cells  arise  by  differentiation  from 
these proto-epithelial  cells; some of this mesenchyme will 
convert  into  epithelia,  which  can  in  some  cases  be  the 
precursor of secondary mesenchyme (e.g., skeletal muscle) 
(Hay,  1990;  Fleming  and Johnson,  1988;  Birchmeier  and 
Birchmeier,  1993). 
It may prove useful therefore to conceptualize the epithe- 
lial cell as a "default phenotype" for mammalian cells. Under 
this model, epithelial gene expression involves only the in- 
terplay  of ubiquitous  transcription  factors.  Tissue-specific 
transcription factors both activate appropriate tissue-specific 
gene expression and repress epithelial-type gene expression 
(e.g., muscle creatine kinase and keratin  18, respectively). 
The  model  predicts  that  epithelial-type  genes  are  under 
repression in non-epithelial cells. A relevant example of this 
is the epithelial-specific promoter of the human papilloma 
virus p97 gene. Its epithelial transcription  is driven purely 
by "ubiquitous" activator proteins, including the factor NF- 
1/CTE Fibroblasts express both NF-1/CTF and an additional 
NF-1 family member (called NF-1X) that represses transcrip- 
tion  through  the  NF-1  sites  of the  promoter  (Apt et al., 
1993). 
The default phenotype model suggests that the epithelial 
conversion effects of Ela may largely reflect de-repression of 
epithelial promoters resulting from inhibition of the expres- 
sion or transcriptional activities of non-epithelial transcrip- 
tion factors. Analysis of the interactions of Ela with cellular 
proteins  will reveal the first step of the process.  The NH2 
terminus of Ela interacts with several potentially global tran- 
scriptional  regulators.  These include:  (a) p300,  a  nuclear 
DNA-binding phosphoprotein  (reviewed in Moran,  1993); 
(b) Dr-I, which itself interacts with TATA box binding pro- 
tein (inostroza et al.  1992); (c) helix-loop-helix domains of 
(at least) myogenin and El2 (Taylor et al.,  1993) which may 
be involved in cell differentiation. The role of retinoblastoma 
protein binding to Ela is unclear in this context.  Although 
this protein regulates the transcription factor E2F, the known 
target genes for this factor are ubiquitously expressed, cell 
cycle-related genes such as c-myc and DHFR (reviewed in 
Nevins,  1992). 
Although the significance of this work is primarily in the 
molecular biology of cell differentiation,  it also may be in- 
formative to consider a new function of Ela for adenovirus. 
Adenovirus  has evolved to infect human  airway epithelial 
cells. However, it it infects a non-epithelial cell (e.g., tonsil- 
lar  fibroblast)  a  gene  such as Ela could be of substantial 
benefit  to  the  virus.  By  altering  the  transcriptional  ma- 
chinery of the cell to (even modestly) activate epithelial-type 
promoters,  Ela would presumably stimulate the transcrip- 
tion  of adenovirus promoters  even in the originally  inap- 
propriate host cell type. This would allow some probability 
of viral life cycle completion. 
In summary, the conversion into an epithelial phenotype 
caused by Ela provides a new system for investigating the in- 
tracellular  mechanisms  by  which  epithelial  and  mesen- 
chymal cells interconvert during development (reviewed in 
Hay, 1990). Because the phenotypic effects of Ela are medi- 
ated by its interactions with a discrete set of cellular proteins 
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to use this phenomenon to molecularly analyze the epithe- 
lial-mesenchymal  transition,  albeit run in reverse.  It also 
may provide a conceptual framework for understanding the 
diversity of transcriptional effects of Ela: by altering a master 
switch that converts a mesenchymal cell to an epithelial cell, 
the  transcription  of  a  large  number  of  genes  could  be 
affected. 
The tumor suppressive effect of Ela may result in part from 
its induction of intercellular adhesion molecules (Tsukita et 
al.,  1993),  which may provide a new approach for under- 
standing and controlling cancer. In particular, epithelial cells 
containing junctional complexes are sensitive to anoikis,  a 
form of apoptosis induced by the disruption of cell-matrix 
interactions (Frisch and Francis,  1994; Ruoslahti and Reed, 
1994). 
Finally, it is interesting that the cells of the mouse morula 
or blastoeyst contain an Ela-like functional (i.e.,  transcrip- 
tional) activity (Suemori et al.,  1988).  This activity disap- 
pears upon implantation of the embryo.  Conceivably,  there 
is a cellular gene functionally analogous to Ela that main- 
tains the epithelial phenotype during early development. 
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